1. A Single Office-Based Stool Blood Test (FOBT) Is a Poor, but Often Used, Screening Test for Colorectal Cancer Two articles and an editorial in the Jan. 18, 2005, Annals of Internal Medicine discuss ...

TO THE EDITORS:In the July issue of The American Journal of Managed Care, Schroy et al 1 reported on preferences for colorectal cancer (CRC) screening tests in relation to currently recommended ...

Nothing elicits a groan from patients as quickly as discussion of uncomfortable screening procedures. Yet those discussions must take place. Colorectal cancer is the third-most common cancer in the ...

For patients with a positive fecal occult blood test in a cohort study, those who did not undergo a follow-up colonoscopy had an increased incidence of colorectal cancer. Those who underwent ...

Impact on stage distribution of gastric cancer by the National Cancer Screening Program (NCSP) in Korea. Background: Mass screening programs for colorectal cancer are based on fecal occult blood test ...

Please provide your email address to receive an email when new articles are posted on . Patients who received a positive fecal occult blood test as an initial screening for colorectal cancer may need ...

Please provide your email address to receive an email when new articles are posted on . The COVID-19 pandemic created new barriers for colorectal cancer screening. However, fecal occult blood tests ...

Last Monday I got my “At-Home Stool Test Kit” in the mail. This test is called “fecal immunochemical tests” (FITs). This test is done at home and detects tiny amounts of blood in your stool, which is ...

Evaluating the clinical utility of universal screening to identify Lynch syndrome in stage III/III colorectal cancer patients: A prospective observational study in Japan. ACPS Stage RFS/PFS Hazard ...

Fecal occult-blood testing (FOBT) is a noninvasive, effective means of screening for colorectal cancer (CRC). The SENSITIVITY of this technique is suboptimal, however, and identification of a simple, ...

Expensive colonoscopies that cost a patient over $1,000 on average could soon be replaced by simpler and much cheaper tests as non-invasive screening options become more available and more ...